![](/img/cover-not-exists.png)
Baseline prevalence and predictors of liver fibrosis among HIV-positive individuals: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
Matthews, GV, Neuhaus, J, Bhagani, S, Mehta, SH, Vlahakis, E, Doroana, M, Naggie, S, Arenas-Pinto, A, Peters, L, Rockstroh, JKVolume:
16
Language:
english
Journal:
HIV Medicine
DOI:
10.1111/hiv.12241
Date:
April, 2015
File:
PDF, 208 KB
english, 2015